This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Jan;68(1):5-7.

doi: 10.1136/thoraxjnl-2012-202482.

Tiotropium Respimat increases the risk of mortality

Christine R Jenkins, Richard Beasley

PMID: 23229813
DOI: 10.1136/thoraxjnl-2012-202482

Editorial

Tiotropium Respimat increases the risk of mortality

Christine R Jenkins et al. Thorax. 2013 Jan.

. 2013 Jan;68(1):5-7.

doi: 10.1136/thoraxjnl-2012-202482.

Authors

Christine R Jenkins, Richard Beasley

PMID: 23229813
DOI: 10.1136/thoraxjnl-2012-202482

Erratum in

Thorax. 2013 Feb;68(2):162

No abstract available

PubMed Disclaimer

Comment in

Explaining differential effects of tiotropium on mortality in COPD.
Lipworth BJ, Short PM. Lipworth BJ, et al. Thorax. 2013 Jun;68(6):589-90. doi: 10.1136/thoraxjnl-2012-203176. Epub 2013 Jan 31. Thorax. 2013. PMID: 23370440 No abstract available.
Thorax editorial by Jenkins and Beasley related to tiotropium respimat.
Metzdorf N, Hallmann C, Disse B. Metzdorf N, et al. Thorax. 2013 Aug;68(8):782. doi: 10.1136/thoraxjnl-2013-203228. Epub 2013 Feb 12. Thorax. 2013. PMID: 23404839 No abstract available.
Authors' reply to 'explaining differential effects of tiotropium on mortality in COPD'.
Jenkins C, Beasley R. Jenkins C, et al. Thorax. 2013 Jun;68(6):590-1. doi: 10.1136/thoraxjnl-2013-203238. Thorax. 2013. PMID: 23802285 No abstract available.
Authors' response to Metzdorf et al.
Jenkins CR, Beasley R. Jenkins CR, et al. Thorax. 2013 Aug;68(8):782-3. doi: 10.1136/thoraxjnl-2013-203380. Epub 2013 Mar 5. Thorax. 2013. PMID: 23842819 No abstract available.

Similar articles

Tiotropium Respimat increases the risk of mortality: pro.
Beasley R. Beasley R. Eur Respir J. 2013 Sep;42(3):584-9. doi: 10.1183/09031936.00042113. Eur Respir J. 2013. PMID: 24000251 No abstract available.
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Singh S, Loke YK, Enright P, Furberg CD. Singh S, et al. Postgrad Med J. 2014 Apr;90(1062):205-7. doi: 10.1136/postgradmedj-2011-201275rep. Postgrad Med J. 2014. PMID: 24643260
The safety of tiotropium--the FDA's conclusions.
Michele TM, Pinheiro S, Iyasu S. Michele TM, et al. N Engl J Med. 2010 Sep 16;363(12):1097-9. doi: 10.1056/NEJMp1008502. Epub 2010 Sep 8. N Engl J Med. 2010. PMID: 20843240 No abstract available.
Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis.
Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA. Rodrigo GJ, et al. Respir Med. 2009 Oct;103(10):1421-9. doi: 10.1016/j.rmed.2009.05.020. Epub 2009 Jun 24. Respir Med. 2009. PMID: 19556116 Review.
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Singh S, Loke YK, Enright P, Furberg CD. Singh S, et al. Thorax. 2013 Jan;68(1):114-6. doi: 10.1136/thoraxjnl-2011-201275. Epub 2012 Jul 4. Thorax. 2013. PMID: 22764216 Review.

See all similar articles

Cited by

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.
Trotta F, Spila-Alegiani S, Da Cas R, Rajevic M, Conti V, Venegoni M, Rossi M, Traversa G. Trotta F, et al. PLoS One. 2017 Apr 21;12(4):e0176276. doi: 10.1371/journal.pone.0176276. eCollection 2017. PLoS One. 2017. PMID: 28430820 Free PMC article.
Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma.
Alvarado-Gonzalez A, Arce I. Alvarado-Gonzalez A, et al. J Clin Med Res. 2015 Nov;7(11):831-9. doi: 10.14740/jocmr2305w. Epub 2015 Sep 25. J Clin Med Res. 2015. PMID: 26491494 Free PMC article. Review.
Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD.
Muruganandan S, Jayaram L. Muruganandan S, et al. Int J Chron Obstruct Pulmon Dis. 2015 Jun 18;10:1179-89. doi: 10.2147/COPD.S54154. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26124657 Free PMC article. Review.
Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study.
Trotta F, Da Cas R, Rajevic M, Rossi M, Traversa G. Trotta F, et al. BMJ Open. 2015 May 25;5(5):e006619. doi: 10.1136/bmjopen-2014-006619. BMJ Open. 2015. PMID: 26009573 Free PMC article.
The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods.
Kardos P, Vogelmeier C, Buhl R, Criée CP, Worth H. Kardos P, et al. BMC Pulm Med. 2015 Jan 12;15:2. doi: 10.1186/1471-2466-15-2. BMC Pulm Med. 2015. PMID: 25578330 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information